Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CNTA

Centessa Pharmaceuticals (CNTA)

Centessa Pharmaceuticals PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CNTA
DateTimeSourceHeadlineSymbolCompany
12/12/20226:37AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTACentessa Pharmaceuticals PLC
12/10/20223:30PMGlobeNewswire Inc.Centessa Pharmaceuticals Announces Additional 18-Months of Continued Treatment Data from Open-Label Extension (OLE) of Phase 2a Study of SerpinPC for HemophiliaNASDAQ:CNTACentessa Pharmaceuticals PLC
12/05/20224:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
12/05/20224:40PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/30/20228:00AMGlobeNewswire Inc.Centessa Pharmaceuticals Announces New Chief People Officer Karen AndersonNASDAQ:CNTACentessa Pharmaceuticals PLC
11/28/20225:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Centessa Pharmaceuticals plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2022 - (NASDAQ: CNTA)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/23/20225:08PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/23/20225:06PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/23/20225:05PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/23/20225:00PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/23/20224:59PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/23/20224:58PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/18/20225:45AMPR Newswire (US)CNTA SHAREHOLDER ALERT: Jakubowitz Law Reminds Centessa Shareholders of a Lead Plaintiff Deadline of November 28, 2022NASDAQ:CNTACentessa Pharmaceuticals PLC
11/16/202210:50PMPR Newswire (US)FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Centessa Pharmaceuticals plc - CNTANASDAQ:CNTACentessa Pharmaceuticals PLC
11/16/20225:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Centessa Pharmaceuticals plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2022 - (NASDAQ: CNTA)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/11/20225:45AMPR Newswire (US)CNTA SHAREHOLDER ALERT: Jakubowitz Law Reminds Centessa Shareholders of a Lead Plaintiff Deadline of November 28, 2022NASDAQ:CNTACentessa Pharmaceuticals PLC
11/10/20227:10AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/10/20227:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/10/20227:00AMGlobeNewswire Inc.Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2022NASDAQ:CNTACentessa Pharmaceuticals PLC
11/09/20225:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Centessa Pharmaceuticals plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2022 - (NASDAQ: CNTA)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/04/20225:45AMPR Newswire (US)CNTA SHAREHOLDER ALERT: Jakubowitz Law Reminds Centessa Shareholders of a Lead Plaintiff Deadline of November 28, 2022NASDAQ:CNTACentessa Pharmaceuticals PLC
11/03/20224:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/03/20229:04AMGlobeNewswire Inc.Centessa Pharmaceuticals to Present Additional 18-Months of Continued Treatment Data with SerpinPC from Open-Label Extension of Phase 2a Study at 64th ASH Annual Meeting NASDAQ:CNTACentessa Pharmaceuticals PLC
11/02/202210:50PMPR Newswire (US)FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Centessa Pharmaceuticals plc - CNTANASDAQ:CNTACentessa Pharmaceuticals PLC
11/02/20225:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Centessa Pharmaceuticals plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2022 - (NASDAQ: CNTA)NASDAQ:CNTACentessa Pharmaceuticals PLC
10/31/20228:00AMGlobeNewswire Inc.Centessa Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:CNTACentessa Pharmaceuticals PLC
10/28/20225:45AMPR Newswire (US)CNTA SHAREHOLDER ALERT: Jakubowitz Law Reminds Centessa Shareholders of a Lead Plaintiff Deadline of November 28, 2022NASDAQ:CNTACentessa Pharmaceuticals PLC
10/21/20225:45AMPR Newswire (US)CNTA SHAREHOLDER ALERT: Jakubowitz Law Reminds Centessa Shareholders of a Lead Plaintiff Deadline of November 28, 2022NASDAQ:CNTACentessa Pharmaceuticals PLC
10/19/202210:50PMPR Newswire (US)FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Centessa Pharmaceuticals plc - CNTANASDAQ:CNTACentessa Pharmaceuticals PLC
10/19/20225:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Centessa Pharmaceuticals plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2022 - (NASDAQ: CNTA)NASDAQ:CNTACentessa Pharmaceuticals PLC
 Showing the most relevant articles for your search:NASDAQ:CNTA